European College of Neuropsychopharmacology (ECNP)

European College of Neuropsychopharmacology (ECNP) Independent scientific association dedicated to the science and treatment of disorders of the brain.

๐Ÿ“ข ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ โ€“ ๐—”๐—ฝ๐—ฝ๐—น๐˜† ๐˜๐—ผ๐—ฑ๐—ฎ๐˜†!Applications for the ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐— ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ๐˜€ close ...
23/06/2026

๐Ÿ“ข ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ โ€“ ๐—”๐—ฝ๐—ฝ๐—น๐˜† ๐˜๐—ผ๐—ฑ๐—ฎ๐˜†!
Applications for the ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐— ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ๐˜€ close today, ๐Ÿฎ๐Ÿฏ ๐—๐˜‚๐—ป๐—ฒ ๐—ฎ๐˜ ๐Ÿญ๐Ÿณ.๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ฆ๐—ง.
Taking place 18โ€“20 November 2026 in Barcelona, Spain โ˜€๏ธ, this three-day, in-person workshop is designed for early-career clinicians and researchers. It offers practical training in clinical research methodology and the critical evaluation of scientific literature, supporting high-quality, evidence-based clinical practice.
โณ Donโ€™t miss your chance to apply before the deadline.
๐Ÿ”— www.ecnp.eu/workshop-methods
๐Ÿ” Explore the programme: www.ecnp.eu/meetings/workshop-on-clinical-research-methods/programme2026/ #!sessionschedule

๐Ÿ“ข ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ โ€” ๐—”๐—ฝ๐—ฝ๐—น๐˜† ๐—ง๐—ข๐——๐—”๐—ฌ ๐Ÿฎ๐Ÿฏ ๐—๐˜‚๐—ป๐—ฒ ๐—ฎ๐˜ ๐Ÿญ๐Ÿณ.๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ฆ๐—ง and join the ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ...
23/06/2026

๐Ÿ“ข ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—˜๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ฒ โ€” ๐—”๐—ฝ๐—ฝ๐—น๐˜† ๐—ง๐—ข๐——๐—”๐—ฌ ๐Ÿฎ๐Ÿฏ ๐—๐˜‚๐—ป๐—ฒ ๐—ฎ๐˜ ๐Ÿญ๐Ÿณ.๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ฆ๐—ง and join the ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐— ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ๐˜€.
๐Ÿ“ Barcelona, Spain โ˜€๏ธ
๐Ÿ—“ 18โ€“20 November 2026
This 3โ€‘day, inโ€‘person workshop is designed for earlyโ€‘career clinicians and researchers looking to strengthen their skills in:
๐Ÿ”ฌ Clinical research methodology
๐Ÿ“š Critical evaluation of scientific literature

๐Ÿ”— Explore the programme and apply via the link in bio.

๐—ก๐—ฒ๐˜„ ๐—˜๐—–๐—ก๐—ฃ ๐—ฐ๐—ผ๐˜‚๐—ฟ๐˜€๐—ฒ ๐—ผ๐—ป ๐—ฃ๐˜€๐˜†๐—ฐ๐—ต๐—ฒ๐—ฑ๐—ฒ๐—น๐—ถ๐—ฐ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต!๐Ÿง  In recent years, interest in the therapeutic potential of psychedelics has rap...
22/06/2026

๐—ก๐—ฒ๐˜„ ๐—˜๐—–๐—ก๐—ฃ ๐—ฐ๐—ผ๐˜‚๐—ฟ๐˜€๐—ฒ ๐—ผ๐—ป ๐—ฃ๐˜€๐˜†๐—ฐ๐—ต๐—ฒ๐—ฑ๐—ฒ๐—น๐—ถ๐—ฐ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต!

๐Ÿง  In recent years, interest in the therapeutic potential of psychedelics has rapidly grown, supported by emerging evidence from preclinical and clinical research.

This new ECNP course provides a comprehensive overview of psychedelic research, covering neurobiological mechanisms, pharmacology, clinical applications, trial design and future directions in mental health care.

Designed for clinicians, researchers and trainees, this course includes:
๐Ÿ”ท 12 expert led lectures covering foundational concepts through to future directions
๐Ÿ”ท Self paced learning with interactive knowledge checks
๐Ÿ”ท Topics include neurobiology, clinical applications, psychotherapy and trial methodology

๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—ป๐˜†๐—ผ๐—ป๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐—ฎ ๐— ๐˜†๐—˜๐—–๐—ก๐—ฃ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐˜‚๐—ป๐˜, with year-round enrolment. The first lectures will be released on 14 September 2026.

๐ŸŽ“ Enrol here: https://ow.ly/OXbv50Zf2In

18/06/2026

๐—ง๐—ต๐—ฒ ๐˜„๐—ฎ๐˜† ๐˜๐—ต๐—ฒ ๐—ช๐—ถ๐—น๐—ฑ ๐—ช๐—ฒ๐˜€๐˜ ๐˜„๐—ฎ๐˜€ ๐˜„๐—ผ๐—ป: ๐—š๐—ฒ๐˜๐˜๐—ถ๐—ป๐—ด ๐—ฟ๐—ฒ๐—ฎ๐—น ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐—บ๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐˜€๐˜€๐˜‚๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ถ๐—ป๐—ด ๐—บ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ (ESM) ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต. Watch this webinar on-demand now โฏ๏ธ

โ€˜To start to address these issues, we developed the ESM-Q, the first consensus-based quality assessment tool and guideline for ESM items.โ€˜

๐ŸŽ™๏ธ Olivia Kirtley, Belgium
Access via the ECNP Knowledge Hub: https://ow.ly/1G2C50Ze9b6

๐Ÿ“Œ ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐— ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ๐˜€ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐ŸฒEarly Career Scientists in Europe: donโ€™t miss out!๐Ÿ“… 18โ€“20 November 2026...
17/06/2026

๐Ÿ“Œ ๐—˜๐—–๐—ก๐—ฃ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐—ผ๐—ป ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐— ๐—ฒ๐˜๐—ต๐—ผ๐—ฑ๐˜€ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ
Early Career Scientists in Europe: donโ€™t miss out!
๐Ÿ“… 18โ€“20 November 2026
๐Ÿ“ Barcelona, Spain โ˜€๏ธ

Join a dynamic three-day Workshop designed specifically for early career clinicians. Gain practical insights into clinical research methodology and develop critical skills for evaluating scientific literatureโ€”essential tools for advancing your clinical practice and research career.

๐Ÿ—“๏ธ Deadline is ๐Ÿฎ๐Ÿฏ ๐—๐˜‚๐—ป๐—ฒ
๐Ÿ”— www.ecnp.eu/workshop-methods

๐Ÿ† ๐—˜๐—–๐—ก๐—ฃ ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—˜๐—–๐—ก๐—ฃ ๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ๐˜€ ๐—ฃ๐—ฟ๐—ถ๐˜‡๐—ฒ ๐˜„๐—ถ๐—ป๐—ป๐—ฒ๐—ฟ: Jolein Odermatt, Switzerland Awarded in recognition of...
15/06/2026

๐Ÿ† ๐—˜๐—–๐—ก๐—ฃ ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ ๐—˜๐—–๐—ก๐—ฃ ๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ๐˜€ ๐—ฃ๐—ฟ๐—ถ๐˜‡๐—ฒ ๐˜„๐—ถ๐—ป๐—ป๐—ฒ๐—ฟ: Jolein Odermatt, Switzerland

Awarded in recognition of her impactful and original research in the ECNP open-access journal, Neuroscience Applied, as the most downloaded research paper in the preceding two years. Her paper is titled:

๐—˜๐—น๐—ฒ๐—ฐ๐˜๐—ฟ๐—ผ๐—ฐ๐—ผ๐—ป๐˜ƒ๐˜‚๐—น๐˜€๐—ถ๐˜ƒ๐—ฒ ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜† ๐—ฟ๐—ฒ๐—ฑ๐˜‚๐—ฐ๐—ฒ๐˜€ ๐˜€๐˜‚๐—ถ๐—ฐ๐—ถ๐—ฑ๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฎ๐—น๐—น-๐—ฐ๐—ฎ๐˜‚๐˜€๐—ฒ ๐—บ๐—ผ๐—ฟ๐˜๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ถ๐—ป ๐—ฟ๐—ฒ๐—ณ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜† ๐—ฑ๐—ฒ๐—ฝ๐—ฟ๐—ฒ๐˜€๐˜€๐—ถ๐—ผ๐—ป: ๐—” ๐˜€๐˜†๐˜€๐˜๐—ฒ๐—บ๐—ฎ๐˜๐—ถ๐—ฐ ๐—ฟ๐—ฒ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—ฎ๐—ป๐—ฑ ๐—บ๐—ฒ๐˜๐—ฎ-๐—ฎ๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ ๐—ผ๐—ณ ๐—ป๐—ฒ๐˜‚๐—ฟ๐—ผ๐˜€๐˜๐—ถ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐˜€๐˜๐˜‚๐—ฑ๐—ถ๐—ฒ๐˜€.

Congratulations! ๐Ÿ‘

Read more: https://ow.ly/Z6o850ZbIor

๐Ÿšจ ๐——๐—ผ๐—ปโ€™๐˜ ๐—บ๐—ถ๐˜€๐˜€ ๐—ง๐—ข๐——๐—”๐—ฌ'๐˜€ ๐—ฃ๐˜€๐˜†๐—ฐ๐—ต๐—ซ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ!What are the risks and how can we better support ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ฑ๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฝ๐—ฟ๐—ฒ๐—ด๐—ป๐—ฎ๐—ป๐—ฐ๐˜† ๐—ฎ๐—ป๐—ฑ ...
08/06/2026

๐Ÿšจ ๐——๐—ผ๐—ปโ€™๐˜ ๐—บ๐—ถ๐˜€๐˜€ ๐—ง๐—ข๐——๐—”๐—ฌ'๐˜€ ๐—ฃ๐˜€๐˜†๐—ฐ๐—ต๐—ซ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ!
What are the risks and how can we better support ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—ฑ๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฝ๐—ฟ๐—ฒ๐—ด๐—ป๐—ฎ๐—ป๐—ฐ๐˜† ๐—ฎ๐—ป๐—ฑ ๐—ฝ๐—ผ๐˜€๐˜๐—ฝ๐—ฎ๐—ฟ๐˜๐˜‚๐—บ?
Explore severe psychiatric disorders with leading experts:
๐ŸŽ™๏ธ Veerle Bergink, USA, & Michele De Prisco, Spain
๐Ÿ—“๏ธ ๐— ๐—ผ๐—ป๐—ฑ๐—ฎ๐˜† ๐Ÿด ๐—๐˜‚๐—ป๐—ฒ
๐Ÿ•“ 16.00 CEST
๐Ÿ”— Access the ECNP Knowledge Hub: https://ow.ly/crjV50Z6eFC

04/06/2026

โฏ๏ธ ๐——๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐˜๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฎ๐—ป๐—ฑ ๐—”๐—œ ๐—ณ๐—ผ๐—ฟ ๐˜๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฒ๐—ป๐—ฑ๐—ฝ๐—ผ๐—ถ๐—ป๐˜๐˜€

Now available on-demand, Georg Dorffner, Austria, presents an overview of:
โ–ถ๏ธ Digital biomarkers for clinical trials in the CNS area
โ–ถ๏ธ The role of AI and machine learning in deriving novel endpoints
โ–ถ๏ธ Common issues in validating such endpoints

Watch here: https://ow.ly/aniv50Z7xrE

As part of the ๐—™๐—ฟ๐—ผ๐—บ ๐——๐—ฎ๐˜๐—ฎ ๐˜๐—ผ ๐—ฉ๐—ฎ๐—น๐˜‚๐—ฒ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ ๐˜€๐—ฒ๐—ฟ๐—ถ๐—ฒ๐˜€ organised by the ECNP Clinical Outcomes Network.

03/06/2026

๐ŸŽฅ ๐—–๐—ฎ๐—น๐—น ๐—ณ๐—ผ๐—ฟ ๐—ฎ๐—ฏ๐˜€๐˜๐—ฟ๐—ฎ๐—ฐ๐˜๐˜€ โ€“ ๐—˜๐—–๐—ก๐—ฃ ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿณ

In this video, Anthony Vernon, United Kingdom, Chair of the ECNP Workshop, encourages Early Career Scientists from Europe to submit their abstracts for the ๐—˜๐—–๐—ก๐—ฃ ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—–๐—ฎ๐—ฟ๐—ฒ๐—ฒ๐—ฟ ๐—ช๐—ผ๐—ฟ๐—ธ๐˜€๐—ต๐—ผ๐—ฝ, taking place ๐Ÿญ๐Ÿดโ€“๐Ÿฎ๐Ÿญ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿณ in ๐—ก๐—ถ๐—ฐ๐—ฒ, ๐—™๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ฒ.

This workshop provides an excellent platform to:
๐Ÿ“Š Share your research and present your data
๐Ÿค Connect with peers across Europe
๐Ÿ’ฌ Gain valuable, constructive feedback from senior experts
๐ŸŒ Strengthen your network within the neuroscience community
If you are an early-career scientist, this is a unique opportunity to engage, learn, and grow.

๐Ÿ‘‰ Learn more and submit your abstract: www.ecnp.eu/workshop/
We look forward to welcoming you in Nice.
King's College London EFPT - European Federation of Psychiatric Trainees Elsevier Life Sciences

Adres

Daltonlaan 400
Utrecht
3584BK

Openingstijden

Maandag 09:00 - 17:30
Dinsdag 09:00 - 17:30
Woensdag 09:00 - 17:30
Donderdag 09:00 - 17:30
Vrijdag 09:00 - 17:30

Telefoon

+31857826670

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer European College of Neuropsychopharmacology (ECNP) nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Organisatie

Stuur een bericht naar European College of Neuropsychopharmacology (ECNP):

Delen